Aminoglycoside Market Will Cross $1.68 Billion By 2022: Grand View Research, Inc.
Global aminoglycoside market is expected to reach
USD 1.68 billion by 2022 growing at an estimated CAGR of 3.5% from 2015 to
2022, according to a new report by Grand View Research, Inc. This expected
growth in demand can be ascribed to the increasing incidences of animal disease
outbreaks leading to high utilization of antibiotics.
North America aminoglycosides market, by drug, 2012 to 2022 (USD Million) |
However,
reduction in prescription rate of aminoglycoside antibiotics due to side
effects associated with usage of these drugs that include severe ototoxicity,
nephrotoxicity, and neuromuscular blockade are expected to affect the market
growth negatively. Furthermore, regulatory disapproval for the usage of certain
aminoglycoside in regions is also anticipated to attribute for subordinate
growth in this industry.
Browse full
research report on Aminoglycoside Market: www.grandviewresearch.com/industry-analysis/aminoglycoside-market
Further key
findings from the report suggest:
- Neomycin
and tobramycin together contributed for over USD 600 million as revenue in
this market owing to higher usage and prescription of these drugs for
treatment of different bacterial infections. Neomycin finds higher usage
in topical formulations for treatment of different skin infections.
- Injectables
accounted for the largest share of revenue amongst other routes of
administration owing to higher usage for treatment of tuberculosis,
MDR-TB, and XDR-TB. Use of second line anti tuberculosis drugs such as
kanamycin & capreomycin by global organizations is attributive for
generation of maximum revenue in this segment.
- Human
use for treatment of respiratory disorders accounted for largest share in
applications segment owing to rise in global incidence of tuberculosis. Furthermore,
other bacterial infections of respiratory tract that can be treated using
aminoglycoside class of antibiotics are anticipated to contribute for
expected growth in this segment.
- Veterinary
treatment is expected to boost industrial growth in the coming years owing
to higher incidence of animal diseases outbreaks. However, these drugs
have restrictive regulations for administration to food-producing animals
as it may lead to toxic effects and resistance development on humans after
consumption of animal originated food.
- Asia
Pacific was the largest market, accounting for over 40% of revenue in
aminoglycoside industry owing to, the presence of market players in this
region coupled with higher rate of tuberculosis incidences herein.
- South
Africa spearheaded growth in the MEA market. The presence of relatively
higher demand and consumption of injectable solutions in this region
because of increase in incidence rate of MDR-TB and other drug resistant
infections are some regional growth drivers.
- Key
participants of the aminoglycoside market include Vega Pharma Ltd.,
Kremoint Pharma Pvt. Ltd, Xian Wison Biological Technology Co., Ltd.,
Jiangxi Bolai Pharmacy Co., Ltd., Medson Pharmaceuticals, Hangzhou Uniwise
International Co., Ltd., Yi Chang Veterinary Medicine Factory, HuvePharma,
and Medico Remedies Pvt. Ltd.
- Market
players are involved in the development of products with newer
formulations and lesser side effects in order to treat eradicate bacterial
infections that are resistant to other class of antibiotics.
Browse more
reports of this category by Grand View Research: www.grandviewresearch.com/industry/biotechnology
Grand View Research has segmented aminoglycoside market on the basis of
product, route of administration, application, and region:
Aminoglycoside
Product Outlook (Market Revenue in USD Million, 2012 - 2022 )
- Neomycin
- Tobramycin
- Gentamicin
- Amikacin
- Paromomycin
- Streptomycin
- Kanamycin
- Others
Aminoglycoside
Outlook, by Route of Administration (Market Revenue in USD Million, 2012 -
2022)
- Injectables
- Feed
- Intra-mammary
- Topical
- Oral
Aminoglycoside
Application Outlook (Market Revenue in USD Million, 2012 - 2022)
- Veterinary
- Skin
Infection
- Respiratory
diseases
- UTI
& Pelvic Diseases
- Other
diseases
Aminoglycoside
Regional Outlook (Revenue, USD Million, 2012 - 2022)
- North
America
- U.S.
- Canada
- Europe
- UK
- Germany
- Asia
Pacific
- China
- Japan
- Latin
America
- Brazil
- MEA
- South Africa
Access
Press Release By Grand View Research: www.grandviewresearch.com/press-release/global-aminoglycoside-market
About Grand
View Research:
Grand
View Research, Inc. is a U.S. based market research and consulting company,
registered in the State of California and headquartered in San Francisco.
The company provides syndicated research reports, customized research
reports, and consulting services. To help clients make informed business
decisions, we offer market intelligence studies ensuring relevant and
fact-based research across a range of industries, from technology to chemicals,
materials and healthcare.
Comments
Post a Comment